TIBSOVI Trademark

Trademark Overview

On Monday, September 26, 2016, a trademark application was filed for TIBSOVI with the United States Patent and Trademark Office. The USPTO has given the TIBSOVI trademark a serial number of 87182786. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 16, 2020. This trademark is owned by Agios Pharmaceuticals, Inc.. The TIBSOVI trademark is filed in the Pharmaceutical Products category with the following description:

anti-cancer preparations, pharmaceutical products for the prevention and treatment of cancer, biological preparations for the treatment of cancer
tibsovi

General Information

Serial Number87182786
Word MarkTIBSOVI
Filing DateMonday, September 26, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 16, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2016

Trademark Statements

Goods and Servicesanti-cancer preparations, pharmaceutical products for the prevention and treatment of cancer, biological preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 29, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAgios Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 021394169
Party NameAgios Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 021394169

Trademark Events

Event DateEvent Description
Monday, March 16, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 16, 2020ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 21, 2019EXTENSION 5 GRANTED
Monday, August 12, 2019EXTENSION 5 FILED
Thursday, August 15, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 12, 2019TEAS EXTENSION RECEIVED
Wednesday, June 12, 2019ASSIGNED TO EXAMINER
Saturday, February 2, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 31, 2019EXTENSION 4 GRANTED
Thursday, January 31, 2019EXTENSION 4 FILED
Thursday, January 31, 2019TEAS EXTENSION RECEIVED
Saturday, August 11, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 9, 2018EXTENSION 3 GRANTED
Thursday, August 9, 2018EXTENSION 3 FILED
Thursday, August 9, 2018TEAS EXTENSION RECEIVED
Thursday, February 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 6, 2018EXTENSION 2 GRANTED
Tuesday, February 6, 2018EXTENSION 2 FILED
Tuesday, February 6, 2018TEAS EXTENSION RECEIVED
Tuesday, August 29, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 16, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 14, 2017EXTENSION 1 GRANTED
Monday, August 14, 2017EXTENSION 1 FILED
Monday, August 14, 2017TEAS EXTENSION RECEIVED
Tuesday, February 14, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 20, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 30, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 10, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 10, 2016ASSIGNED TO EXAMINER
Thursday, September 29, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 29, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

tibsovi cancer treatment preparations prevention biological pharmaceutical anti products